For and against

BMJ

Volumn 321, Issue 7258, 2000, Pages 442-445

  Rothman, Kenneth J ^a   Michels, Karin B ^b   Baum, Michael ^c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CONTROLLED STUDY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMED CONSENT; INTERNATIONAL COOPERATION; MEDICAL ETHICS; MEDICAL RESEARCH; PATIENT RIGHT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STANDARD;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL APPROACH/SOURCE; WORLD MEDICAL ASSOCIATION;

CLINICAL TRIALS; HELSINKI DECLARATION; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; INTERNATIONAL COOPERATION; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0034641552     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.321.7258.442     Document Type: Article

References (21)

1. World Medical Association. Declaration of Helsinki. JAMA, 1997: 277: 925-926.
2. Lasagna L. The Helsinki Declaration: timeless guide or irrelevant anachronism? J Clin Psychopharmacol 1995; 15: 96-98.
3. Levine RJ. The need to revise the Declaration of Helsinki. N Engl J Med 1999; 341: 531-534.
4. Temple R. Government viewpoint of clinical trials. Drug Inf J 1982; 10-17
5. Temple R. Problems in interpreting active control equivalence trials. Accountability in Research 1996; 4: 267-275.
6. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994; 331: 394-398.
7. Rothman KJ. Placebo mania. BMJ 1996; 313: 3-4
8. Freedman B, Weijer C, Glass KC. Placebo orthodoxy in clinical research I: empirical and methodological myths. J Law Med Ethics 1996; 24: 243-251.
9. Freedman B, Weijer C, Glass KC. Placebo orthodoxy in clinical research II: ethical, legal and regulatory myths. J Law Med Ethics 1996; 24: 252-259.
10. Hill AB. Medical ethics and controlled trials. BMJ 1963; 1: 1043-1049.
11. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. When placebo controlled trials are essential and equivalence trials are inadequate. BMJ 1998; 317: 875-880.
12. Shapiro AK, Shapiro E. The placebo: is it much ado about nothing? In The placebo effect. An interdisciplinary exploration. Harrington A, ed. In: Cambridge: Harvard University Press, 1997.
13. Denny WF. The use of placebo controls. N Engl J Med 1995; 332: 61-62.
14. Nicholson RH. “If it ain't broke, don't fix it.” Hastings Center Report 2000: January-February 6.
15. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317: 141-145.
16. Angell M. Investigators' responsibilities for human subjects in developing countries. N Engl J Med 2000; 342: 967-969.
17. Pragmatism in codes of research ethics. [editorial]. Lancet 1998; 351: 225.
18. Brennan TA. Proposed revisions to the Declaration of Helsinki—will they weaken the ethical principles underlying human research? N Engl J Med 1999; 527-534.
19. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997; 337: 801-808.
20. Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med 1997; 337: 1003-1005.
21. Angell M. The ethics of clinical research in the third world. N Engl J Med 1997; 337: 847-849.